| Theme | The New Guideline for Liver Cancer Treatment | |
|---|---|---|
| Title | Local Ablation Therapy for Hepatocellular Carcinoma | |
| Publish Date | 2018/06 | |
| Author | Yasunori Minami | Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine |
| Author | Masatoshi Kudo | Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine |
| [ Summary ] | Revised points of the 2017 edition about local ablation therapy were as follows: 1) For the combination therapy transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA), the clinical recommendation was promoted as "Survival could be improved by the combination TACE and RFA in patients with larger size HCC", 2) A new clinical question, "What are predictive factors for treatment response in local ablation therapy?", was added. The remaining four clinical questions (CQs) were removed from the previous edition and the recommendations of these of CQs were followed in the latest edition. | |